Azat Garipov

1.1k total citations · 1 hit paper
6 papers, 837 citations indexed

About

Azat Garipov is a scholar working on Molecular Biology, Biotechnology and Cancer Research. According to data from OpenAlex, Azat Garipov has authored 6 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Biotechnology and 2 papers in Cancer Research. Recurrent topics in Azat Garipov's work include RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (2 papers) and Cancer-related molecular mechanisms research (2 papers). Azat Garipov is often cited by papers focused on RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (2 papers) and Cancer-related molecular mechanisms research (2 papers). Azat Garipov collaborates with scholars based in United States, Russia and France. Azat Garipov's co-authors include Rugang Zhang, Benjamin G. Bitler, Katherine M. Aird, José R. Conejo-García, Michael Amatangelo, David W. Speicher, Andrew V. Kossenkov, D. Schultz, Hua Li and Qin Liu and has published in prestigious journals such as Nature Medicine, Cell Reports and Cell Cycle.

In The Last Decade

Azat Garipov

6 papers receiving 828 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers

2015 492 citations Benjamin G. Bitler, Katherine M. Aird et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Azat Garipov United States	6	679	204	182	168	83	6	837
Zelda Lichtensztejn Canada	17	423 0.6×	109 0.5×	175 1.0×	85 0.5×	39 0.5×	23	579
Dragana Kopanja United States	16	624 0.9×	136 0.7×	230 1.3×	62 0.4×	20 0.2×	20	739
Tchaiko Parris United States	4	543 0.8×	193 0.9×	118 0.6×	272 1.6×	22 0.3×	4	669
Steve Baylin United States	4	341 0.5×	156 0.8×	148 0.8×	117 0.7×	35 0.4×	4	499
Jen‐Lan Tsao United States	13	457 0.7×	345 1.7×	272 1.5×	491 2.9×	37 0.4×	14	834
Evelyn Despierre Belgium	13	420 0.6×	298 1.5×	156 0.9×	85 0.5×	373 4.5×	17	914
Clara Salamanca Canada	12	382 0.6×	170 0.8×	178 1.0×	76 0.5×	290 3.5×	15	708
Yi-Tzu Lin United States	12	903 1.3×	275 1.3×	275 1.5×	37 0.2×	103 1.2×	14	1.1k
Olga Kim South Korea	14	289 0.4×	196 1.0×	135 0.7×	40 0.2×	113 1.4×	31	570
Susan Morgan United Kingdom	10	236 0.3×	55 0.3×	187 1.0×	87 0.5×	27 0.3×	18	445

Countries citing papers authored by Azat Garipov

Since Specialization

Citations

This map shows the geographic impact of Azat Garipov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azat Garipov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azat Garipov more than expected).

Fields of papers citing papers by Azat Garipov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azat Garipov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azat Garipov. The network helps show where Azat Garipov may publish in the future.

Co-authorship network of co-authors of Azat Garipov

This figure shows the co-authorship network connecting the top 25 collaborators of Azat Garipov. A scholar is included among the top collaborators of Azat Garipov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azat Garipov. Azat Garipov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Zelenikhin, Pavel, et al.. (2016). Obvious and Hidden Reasons of Breast Cancer Cell Sensitivity to Antitumor RNase. BioNanoScience. 6(4). 528–533. 5 indexed citations

2.

Bitler, Benjamin G., Katherine M. Aird, Azat Garipov, et al.. (2015). Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers. Nature Medicine. 21(3). 231–238. 492 indexed citations breakdown →

3.

Garipov, Azat, et al.. (2014). Bacillus intermedius ribonuclease (BINASE) induces apoptosis in human ovarian cancer cells. Toxicon. 92. 54–59. 15 indexed citations

4.

Garipov, Azat, Hua Li, Benjamin G. Bitler, et al.. (2013). NF-YA Underlies EZH2 Upregulation and Is Essential for Proliferation of Human Epithelial Ovarian Cancer Cells. Molecular Cancer Research. 11(4). 360–369. 51 indexed citations

5.

Amatangelo, Michael, Azat Garipov, Hua Li, et al.. (2013). Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition. Cell Cycle. 12(13). 2113–2119. 64 indexed citations

6.

Aird, Katherine M., Gao Zhang, Hua Li, et al.. (2013). Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence. Cell Reports. 3(4). 1252–1265. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact